EU AI Act Readiness Check

Your AI system's high-risk classification under Art. 6 EU AI Act is either on the table or already made. This check tests whether risk management, data governance, technical documentation, human oversight and post-market monitoring under Art. 8-15 and Art. 72 are actually documented, not just considered.

Question 1 of 12

Is your AI system formally and documented classified under Art. 6 (product path Art. 6(1) via MDR/IVDR, or the use-case list in Annex III)?

Without a documented classification, nothing counts as settled in an audit, EU AI Act Art. 6.

Orientation only, not a substitute for a regulatory assessment.

Image notice: The images on this page were generated using artificial intelligence. They do not depict real people, places, or events.

MHRA and Manchester NHS launch a health innovation sandbox: an early signal for AI-enabled devices

The Manchester Sandbox moves the evidence conversation for AI-enabled medical devices into real NHS settings. It is a regulator-enabled evidence environment, not a new authorization pathway, and key operational details have not been published.

ArticleAug 25, 2026

FDA and generative AI: no new policy, but a regulatory framework is taking shape

On 18 August 2026 the FDA published its discussion paper on the regulation of generative AI-enabled medical devices. It is not draft guidance, not final guidance and not a new policy statement. It should not, however, be dismissed as merely exploratory.

ArticleJun 18, 2026

Computer System Validation: Two New Standards, One 12-Week Window

The revised Annex 11 is in final consultation. Annex 22 sits alongside it in draft: the EU's first dedicated guidance on AI in GMP manufacturing. Read them side by side and the message is the same. The bar for trusting a computerised system is moving up.

Need support with implementation?

The tool provides initial guidance. For your specific situation, we clarify the right approach in a first call.

Speak with an expert All consulting formats